HealthcareServices

Global Cannabis Pharmaceuticals Market Report 2026–2035: Key Forecasts and Growth Areas

February 20, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cannabis pharmaceuticals market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Cannabis Pharmaceuticals Market between 2026 and 2030?

The cannabis pharmaceuticals market has witnessed rapid expansion in recent years. It is forecast to rise from $9.43 billion in 2025 to $14.74 billion in 2026, registering a compound annual growth rate (CAGR) of 56.3%. The market’s historical development can be ascribed to several factors, including the growing acceptance of cannabinoids’ therapeutic benefits, the increase in medical cannabis prescriptions, the availability of early cannabis-based drugs, the expansion of hospital-based pain management initiatives, and regulatory approvals for certain cannabis pharmaceuticals.

The cannabis pharmaceuticals market is projected for remarkable expansion over the coming years, with its valuation set to reach $85.68 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 55.3%. This anticipated growth stems from several factors, including escalating investments in clinical trials for cannabis-derived drugs, a surging need for consistent cannabinoid formulations, broader applications in neurology and oncology, increased integration of cannabis pharmaceuticals within hospital settings, and greater alignment of regulations across various markets. Key trends anticipated during this period encompass the accelerated creation of prescription-strength cannabis medicines, a heightened focus on clinical validation and extensive trials, expanded therapeutic use in neurological conditions and pain management, the enlargement of regulated pharmaceutical development pipelines, and a stronger emphasis on precise dosing.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20723&type=smp

Which Drivers Are Expected To Impact The Cannabis Pharmaceuticals Market During The Forecast Period?

An anticipated increase in epilepsy cases is projected to fuel the expansion of the cannabis pharmaceuticals market moving ahead. Epilepsy is defined as a neurological condition marked by repeated, spontaneous seizures resulting from atypical electrical activity within the brain. This increase in epilepsy occurrences can be linked to improved diagnostic methods, greater public awareness, and more comprehensive reporting, in addition to potential environmental, genetic, and lifestyle factors. Cannabis-based medications have demonstrated promise in managing epilepsy by employing cannabinoids such as CBD to lessen the occurrence and intensity of seizures for individuals unresponsive to conventional anti-epileptic treatments. As an illustration, the World Health Organization, a Switzerland-based global health agency, reported in February 2024 that the global population affected by epilepsy had climbed to approximately 50 million in 2024. Consequently, the growing prevalence of epilepsy is propelling the development of the cannabis pharmaceuticals market.

How Is The Cannabis Pharmaceuticals Market Divided Into Segments?

The cannabis pharmaceuticals market covered in this report is segmented –

1) By Product Type: Cannabinoid-Based Pharmaceuticals, Synthetic Cannabinoids

2) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Government-Authorized Medical Cannabis Dispensaries

Subsegments:

1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations

2) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists

What Upcoming Trends Are Likely To Define The Future Path Of The Cannabis Pharmaceuticals Market?

Major enterprises in the cannabis pharmaceuticals sector are concentrating on creating novel products, such as sophisticated medical cannabis formulations, to tackle various medical ailments and enhance patient results. These advanced medical cannabis formulations are specifically engineered cannabis-based offerings, refined for therapeutic application, incorporating exact quantities of cannabinoids such as THC and CBD. For instance, in April 2024, Canexis Pharma AG, a pharmaceutical firm based in Switzerland, secured manufacturing and narcotics licenses for cannabis pharmaceuticals from Swissmedic. These authorizations enable the company to produce high-quality medicinal active ingredients derived from CBD and THC. This development positions Canexis to cater to the increasing demand for medical cannabis both within Switzerland and internationally. By acquiring these licenses, the company showcases its adherence to rigorous regulatory benchmarks, thereby bolstering its trustworthiness and capacity to contribute to the rapidly expanding medical cannabis market.

Which Key Players Are Driving Competition In The Cannabis Pharmaceuticals Market?

Major companies operating in the cannabis pharmaceuticals market are Tilray Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Aphria Inc., Cronos Group, GW Pharmaceuticals plc, Jazz Pharmaceuticals plc, Organigram Holdings Inc., Aleafia Health Inc., Avicanna Inc., Enveric Biosciences Inc., Auxly Cannabis Group Inc., Emerald Health Therapeutics Inc., Medical Marijuana Inc., Valens Company Inc., Curaleaf Holdings Inc., Trulieve Cannabis Corp., Green Thumb Industries Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cannabis-pharmaceuticals-global-market-report

Which Region Is Projected To Lead The Cannabis Pharmaceuticals Market During The Forecast Period?

North America was the largest region in the cannabis pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cannabis Pharmaceuticals Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20723&type=smp

Browse Through More Reports Similar to the Global Cannabis Pharmaceuticals Market 2026, By The Business Research Company

Cannabis Cultivation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-cultivation-global-market-report

Cannabis Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795